Marinesco-Sjogren syndrome
MONDO:0009567Marinesco-Sjogren syndrome (MSS) belongs to the group of autosomal recessive cerebellar ataxias. Cardinal features of MSS are cerebellar ataxia, congenital cataract, and delayed psychomotor development.
Also known as: MSS, Marinesco-Sjogren syndrome, Marshall Smith Syndrome, Marinesco-Sjogren syndrome-Hypergonadotrophic hypogonadism, Marinesco-Sjogren syndrome-myopathy, Marinesco-Sjogren-Garland syndrome, Marinesco-Sjögren syndrome
28 clinical trials for this condition and its sub-types, 10 tagged with Marinesco-Sjogren syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New cocktail approach aims to wipe out High-Risk rectal cancer without surgery
Disease control CompletedThis phase 2 trial tests a powerful mix of short-course radiation, chemotherapy (mFOLFOX6), an immunotherapy (PD-1 antibody), and a targeted drug (cetuximab or bevacizumab, depending on genetic markers) in people with high-risk rectal cancer that is mismatch repair proficient (pM…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat liver metastases in colorectal cancer
Disease control CompletedThis trial tests a personalized treatment plan for people with advanced colorectal cancer that has spread to the liver and stopped responding to standard treatments. The approach combines a liver-directed chemotherapy (HAIC), a targeted therapy (fruquintinib or cetuximab), and an…
Sponsor: Peking University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC